Journal: Neurocritical Care

Article Title: Altered Neurocritical Care Management of Patients with Severe Traumatic Brain Injury Following Changed Positions of the Zero-Reference Points for Intracranial and Arterial Pressure Measurement

doi: 10.1007/s12028-025-02366-2

Figure Lengend Snippet: Total doses of metoprolol ( a ) and clonidine ( b ) during the entire neurocritical care unit stay in patients treated between 2013 and 2016 ( a : 24 patients; b : 31 patients) and 2018 and 2022 ( a : 7 patients; b : 26 patients). Although no significant differences in clonidine treatment were found, the use of metoprolol was significantly lower in patients treated after change of the arterial blood pressure transducer position in 2018–2022. Data are shown as median, interquartile range, and range

Article Snippet: Physiological variables (e.g., ICP, CPP, and MAP) and total doses of barbiturates, metoprolol, clonidine, and norepinephrine were obtained from IntelliSpace Critical Care & Anesthesia (Philips).

Techniques:

Journal: Neurocritical Care

Article Title: Altered Neurocritical Care Management of Patients with Severe Traumatic Brain Injury Following Changed Positions of the Zero-Reference Points for Intracranial and Arterial Pressure Measurement

doi: 10.1007/s12028-025-02366-2

Figure Lengend Snippet: Total doses of norepinephrine during the entire neurocritical care unit stay in patients treated between 2013 and 2016 (20 patients) and 2018 and 2022 (50 patients). A statistically significant increase in total doses of norepinephrine in 2018–2022 is noted. Data are shown as median, interquartile range, and range

Article Snippet: Physiological variables (e.g., ICP, CPP, and MAP) and total doses of barbiturates, metoprolol, clonidine, and norepinephrine were obtained from IntelliSpace Critical Care & Anesthesia (Philips).

Techniques:

Journal: Acta Radiologica Open

Article Title: MRI T1 relaxation time for evaluating early complete response to neoadjuvant treatment in rectal cancer: measurement at six weeks – a protocol article

doi: 10.1177/20584601251362322

Figure Lengend Snippet: 54y female, with an annular tumour (marked with green) in the lower part of the rectum. The figure originates from the IntelliSpace software. (A1) displays the T1 weighted relaxation time sequence and (A2) on the right displays the derived T1 map in yellow and blue colours. This tumour has a relaxation time of 1356 milliseconds at time of staging. Bright yellow areas represent a higher relaxation time as per the colour scale on the far. (B1) and (B2) show the tumour with reduced thickness after neoadjuvant radio chemotherapy, 62 Gray/28 fractions concomitant with capecitabine. Relaxation time at this point is 1103 milliseconds.

Article Snippet: The T1 maps are processed using IntelliSpace software (Koninklijke Philips N.V., Amsterdam, The Netherlands), which allows quantitative measurement of T1RT [ms].

Techniques: Software, Sequencing, Derivative Assay